Medical therapies in pituitary adenomas: Current rationale for the use and future perspectives. - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Annales d'Endocrinologie = Annals of Endocrinology Année : 2015

Medical therapies in pituitary adenomas: Current rationale for the use and future perspectives.

Résumé

Pituitary adenomas (PA) represent in the majority of cases, benign tumors whose treatment currently associate surgery, medical therapies and radiotherapy in a multidisciplinary approach. While trans-sphenoidal surgery remains, except for prolactin-secreting adenomas, the first-line treatment of PA, it can considerably be hampered by the existence of an invasive and/or aggressive tumor for which medical therapies are often requested. In this review, we extensively discuss, both at molecular and clinical levels, the medical therapies currently used and in development in the different phenotypes of pituitary adenomas.
Fichier non déposé

Dates et versions

hal-01176930 , version 1 (16-07-2015)

Identifiants

  • HAL Id : hal-01176930 , version 1
  • PUBMED : 25556152

Citer

Thomas Cuny, Anne A. Barlier, Richard Feelders, Georges Weryha, Leo J Hofland, et al.. Medical therapies in pituitary adenomas: Current rationale for the use and future perspectives.. Annales d'Endocrinologie = Annals of Endocrinology, 2015, 76 (1), pp.43-58. ⟨hal-01176930⟩

Collections

CNRS UNIV-AMU
52 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More